2331 GMT - Ansell's bull at RBC sees scope for the stock to continue its recent outperformance on the personal-protective equipment maker's earnings beat and strong outlook. Analyst Craig Wong-Pan, who has a last-published outperform rating on the stock, tells clients in a note that FY 2026 underlying profit beat consensus by 4%. The midpoint of Ansell's FY 2027 EPS guidance is an even stronger beat, sitting 7% ahead at the range midpoint. Wong-Pan highlights good June-half revenue growth across both industrial and healthcare, but notes a A$15 million benefit from customer restocking of exam/single-use gloves. RBC has a target price of 36.00 Australian dollars on the stock, which is at A$34.90 ahead of the open.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.